S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
about
Temporal changes in rat liver gene expression after acute cadmium and chromium exposureThe emerging role of Toll-like receptor 4 in myocardial inflammationResolution of Inflammation: What Controls Its Onset?Application of Functional Genomics for Bovine Respiratory Disease DiagnosticsComparative Proteomics Identifies Host Immune System Proteins Affected by Infection with Mycobacterium bovisMassively parallel digital transcriptional profiling of single cellsAnti-atherogenic properties of resveratrol: 4-week resveratrol administration associated with serum concentrations of SIRT1, adiponectin, S100A8/A9 and VSMCs contractility in a rat model.Establishment a real-time reverse transcription PCR based on host biomarkers for the detection of the subclinical cases of Mycobacterium avium subsp. paratuberculosis.Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cellsCalprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritisThe Association between Serum Uric Acid Levels and the Prevalence of Vulnerable Atherosclerotic Carotid Plaque: A Cross-sectional Study.Calprotectin and platelet aggregation in patients with stable coronary artery diseaseThrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis modelMolecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions.Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface.Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear CellsElevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production.Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in RatsCombining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.Temporal neutrophil polarization following myocardial infarctionTopical application of the anti-microbial chemical triclosan induces immunomodulatory responses through the S100A8/A9-TLR4 pathwayDeficiency of myeloid-related proteins 8 and 14 (Mrp8/Mrp14) does not block inflammaging but prevents steatosis.The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine.Role of macrophages in Wallerian degeneration and axonal regeneration after peripheral nerve injury.Targeting danger-associated molecular patterns after myocardial infarction.The ongoing quest for biomarkers in Ankylosing Spondylitis.Maternal immunity and pregnancy outcome: focus on preconception and autophagy.Transplantation and Damage-Associated Molecular Patterns (DAMPs).S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone.The role of damage- and pathogen-associated molecular patterns in inflammation-mediated vulnerability of atherosclerotic plaques.Expression, Purification, and Antimicrobial Activity of S100A12.Enhanced S100A9 and S100A12 expression in acute coronary syndrome.The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation.Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases.Analysis of region specific gene expression patterns in the heart and systemic responses after experimental myocardial ischemia.Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in miceS100A8/A9 increases the mobilization of pro-inflammatory Ly6Chigh monocytes to the synovium during experimental osteoarthritis.S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice.Hypertrophic preconditioning: short-term tricks for long-term gain.Proinflammatory effects and mechanisms of calprotectin on human gingival fibroblasts.
P2860
Q23918397-D559D99C-D5C3-4881-BF43-6CB310E0C1AFQ26745749-BC17C197-9F1C-4422-B616-6F43ECFE0F74Q26747410-4976BEA6-3D72-4B4F-84D9-527A77AC55BBQ26777353-3552C79D-4ADA-4416-814C-778B5C7A4040Q27303743-900CCA8F-70E2-417E-8F04-19E3450AE4F5Q30835340-5F4E26C6-5EF4-43B1-9C3F-05E1828A8778Q33724276-2C49BFAA-A3B6-4D0E-8D67-0D83EF3A8073Q33728544-1E47A655-A0EB-4A68-B41F-3F11FA48477DQ33783947-923E0B1F-1649-44D5-9398-CF970739C198Q34941693-8DFF9A55-6742-49C4-8045-445875D08047Q35591199-2622ECCE-4683-4B2E-8194-9B5355B375FDQ35603084-BC809A6A-25BE-4E0E-9D2D-BC3FCB1088D9Q35651465-249AC523-C0C2-40F2-B311-BB1DBF1BBA73Q35723326-26F2239F-D14C-4442-9731-EB823C7A6828Q35905318-E5A34E3B-EE3B-42A9-8AAD-977915CAC115Q36261057-52A64AFA-ADEE-4988-83A7-3283CCAFA70BQ36414066-5D281C41-726E-4BD8-AB9F-CC73F7973FE8Q36424996-D74CAC0E-D038-4461-81E8-E973265B161FQ36481310-07BA07C6-B2F5-4634-B613-695F72C1B504Q36702435-8E4AA894-42F7-474F-ABD3-B2E29296C812Q36887993-B79B376D-31FD-40EA-BC6C-BD46AE31C93DQ37392515-CB941137-54D6-4E21-81BC-1796CFACD564Q38519934-1A64EDC6-4BC7-438C-A26D-D68F207643D0Q38595353-F7D04529-B73B-4042-B8CD-09DCF3871B87Q38595544-9F0F8B56-49DD-452B-8167-9991E0FE13EFQ38607774-98171572-121E-4501-960D-1BAEFFC5646EQ38666167-2F07355C-90E4-4986-9168-8EAB065582ECQ38898214-0CD2078F-A437-4DF7-8AB8-991D85C20C29Q38978641-8DE5D1CC-C783-4F26-97F4-82F2A8E39B5AQ39459619-380413FD-4A3D-4405-8ADE-F05E2FA199D9Q40189254-A2B833F2-8F13-4026-BB52-BBF22DB3D34FQ40347116-6DABA7CE-32D9-4BE5-969B-5E01C4BDDAE8Q41350185-32AA77CD-40C5-4839-9F46-38A6D312672CQ41383822-AB2F51C4-816B-406E-B53C-67EE607747E0Q41811962-70A27D36-FEE8-4BC0-A1FC-E27769F974C7Q41852055-7FB2F448-DCC1-4005-A3C1-5F59A69EC1FDQ42288148-DF24CB04-1013-4DD7-85AF-1E159A54C3D8Q42380022-2F58558F-A5DB-4DAE-862F-0DE2FEE8457BQ42565534-79F5599E-A731-48A6-87A1-EDF73687D981Q46345607-449204A7-A699-45DF-AB78-F8E43E1898B2
P2860
S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
S100A8 and S100A9: DAMPs at th ...... s, and cardiovascular disease.
@en
S100A8 and S100A9: DAMPs at th ...... s, and cardiovascular disease.
@nl
type
label
S100A8 and S100A9: DAMPs at th ...... s, and cardiovascular disease.
@en
S100A8 and S100A9: DAMPs at th ...... s, and cardiovascular disease.
@nl
prefLabel
S100A8 and S100A9: DAMPs at th ...... s, and cardiovascular disease.
@en
S100A8 and S100A9: DAMPs at th ...... s, and cardiovascular disease.
@nl
P2860
P921
P356
P1476
S100A8 and S100A9: DAMPs at th ...... rs, and cardiovascular disease
@en
P2093
Ovidiu S Cotoi
P2860
P304
P356
10.1155/2013/828354
P577
2013-12-22T00:00:00Z